Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena Collagen Bank Launch

Kenvue announced the launch of Neutrogena Collagen Bank featuring the company’s patented micro-peptide technology. The launch brings Neutrogena into the pre-aging catefory and is poised to meet the needs of Gen Z, a new generation of consumers. 

Neutrogena Collagen Bank aims to proactively prevent the skin from aging. 

A 2023 Mintel Face Skincare study revealed 58% of Gen Z is worried about aging concerns beginning at 23. 

A press release says Neutrogena Collagen Bank harnesses the power of a patented micro-peptide technology 2 times smaller than the leading anti-aging peptides on the market to penetrate more than 10 layers under the surface of the skin. The release explains the leading anti-aging peptides on the market are too big to penetrate the skin and sit on the surface. 

“Collagen Bank is a cutting-edge solution for a generation of consumers looking to take a preventative approach to skincare,” said Adam Ricciardone, Global head of R&D, Skin Health and Beauty at Kenvue. “We know that millennials and Gen Z are trying a lot of different approaches to their skincare. Our scientifically proven formulation addresses their concerns and prioritizes long-term skin health at the same time.” 

The two dermatologist-tested formulations are Neutrogena Collagen Bank Moisturizer and Neutrogena Collagen Bank Broad Spectrum SPF 30 Moisturizer.